fda compounding semaglutide warning letters news issues 30 to online GLP-1 compounders Compounded GLP-1s: Why doctors worry

For a bariatric practice, this topic is especially helpful because it speaks to people making serious decisions

Microdoses, like all compounded GLP-1 doses, are understudied and not approved by the Food and Drug Administration

Despite significant improvement with completion of a prednisone taper, the rash recurred

Single-use autoinjectors typically do not require priming and may contain small air bubbles by design

Wegovy (semaglutide 2.4 mg) is a prescription medicine licensed in the UK for weight management in adults with obesity or those who are overweight with at least one weight-related comorbidity

Why GLP-1 Treatments May Cause Hair Thinning The mechanism behind hair loss in patients taking GLP-1 medications is not directly related to the drug's pharmacological action on GLP-1 receptors